Walleye Trading LLC Gsk PLC Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $259,901 - $299,089	-6,863 Reduced 39.25%	10,623 $433,000
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $348,597 - $524,238	10,736 Added 159.05%	17,486 $663,000
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $116,072 - $125,794	2,946 Added 77.44%	6,750 $270,000
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $2.04 Million - $2.3 Million	-53,904 Reduced 93.41%	3,804 $145,000
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $2.1 Million - $2.26 Million	52,902 Added 1100.75%	57,708 $2.32 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $17,988 - $21,327	-509 Reduced 9.58%	4,806 $170,000
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $209,623 - $220,838	5,315	5,315 $216,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.